A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers - NCT01045083-92093(Clinical Trial 464350)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
La Jolla |
|
State:
|
|
CA |
| Zip Code: |
|
92093 |
| Conditions: |
|
Healthy Volunteer |
| Purpose: |
|
This is an exploratory study to evaluate the usefulness of fMRI as a biomarker to
characterize the response to three centrally active drugs and placebo.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Adult patients, 18 to 45 years of age
- In good general health
- Weight of ≥120 lbs (55 kg) and a body mass index (BMI) between 18 to 30kg/m²
- Males and females with reproductive potential: willing to use a reliable method of
contraception
Exclusion Criteria:
- Evidence of clinically significant disease
- Medical or surgical condition that could alter the absorption, metabolism, or
elimination of drugs
- Family history of sudden death or ventricular arrhythmia
- History of any psychiatric disorder and/or marked anxiety
- History of glaucoma
- History (including family) of motor tic or diagnosis of Tourette's syndrome
- Active suicide ideation
- Contraindication to MRI |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
October 8, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|